Related Experiment Video

Updated: Apr 19, 2026

Murine Model of Metastatic Liver Tumors in the Setting of Ischemia Reperfusion Injury
05:59

Murine Model of Metastatic Liver Tumors in the Setting of Ischemia Reperfusion Injury

Published on: August 30, 2019

13.1K

Liver metastases from neuroendocrine tumors

Andrew Kennedy

    Future Oncology (London, England)
    |December 6, 2014
    PubMed
    Abstract

    No abstract available in PubMed .

    Keywords:
    ENETS consensusadvanced neuroendocrine tumorslivermetastasesselective internal radiation therapytransarterial chemoembolization

    More Related Videos

    A Portal Vein Injection Model to Study Liver Metastasis of Breast Cancer
    07:35

    A Portal Vein Injection Model to Study Liver Metastasis of Breast Cancer

    Published on: December 26, 2016

    43.4K
    Minimally Invasive Cisterna Magna Injection Model for Leptomeningeal Metastasis Studies in Mice
    07:14

    Minimally Invasive Cisterna Magna Injection Model for Leptomeningeal Metastasis Studies in Mice

    Published on: May 23, 2025

    2.2K

    Related Experiment Videos

    Last Updated: Apr 19, 2026

    Murine Model of Metastatic Liver Tumors in the Setting of Ischemia Reperfusion Injury
    05:59

    Murine Model of Metastatic Liver Tumors in the Setting of Ischemia Reperfusion Injury

    Published on: August 30, 2019

    13.1K
    A Portal Vein Injection Model to Study Liver Metastasis of Breast Cancer
    07:35

    A Portal Vein Injection Model to Study Liver Metastasis of Breast Cancer

    Published on: December 26, 2016

    43.4K
    Minimally Invasive Cisterna Magna Injection Model for Leptomeningeal Metastasis Studies in Mice
    07:14

    Minimally Invasive Cisterna Magna Injection Model for Leptomeningeal Metastasis Studies in Mice

    Published on: May 23, 2025

    2.2K

    Related Concept Videos

    Hepatic Encephalopathy01:29

    Hepatic Encephalopathy

    18
    DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic...
    18

    Articles linked to this work by shared authors, journal, and citation graph.

    What factors influence how belief impacts health interventions? A multidisciplinary scoping review.

    Journal of psychosomatic research·2026

    SMPD3 suppresses oligodendroglioma growth via dual autocrine-paracrine roles.

    Communications biology·2026

    Single-cell gain-of-function mapping reveals latent regulatory programs governing CD8+ T cell fate.

    Research square·2026

    High-avidity cathepsin-G-specific CAR-T cells for the treatment of acute myeloid leukemia.

    Blood·2026

    Development and validation of AI-Enhanced auscultation for valvular heart disease screening through a multi-centre study.

    NPJ cardiovascular health·2026

    Latent Regulatory Programs Generate Synthetic T Cell States with Enhanced Therapeutic Potential.

    bioRxiv : the preprint server for biology·2026

    Prognostic disparities between radioactive iodine-refractory and non-refractory DTC patients: a cohort study on survival rates and independent risk factors.

    Future oncology (London, England)·2026

    Smoldering multiple myeloma: a multi-country mixed-methods study on disease perceptions and patient treatment preferences.

    Future oncology (London, England)·2026

    A pragmatic adaptation of the RANO clinical risk score for IDH-Wildtype glioblastoma in the absence of MGMT promoter methylation testing.

    Future oncology (London, England)·2026

    Clinical and genetic risk factors for anthracycline‑induced cardiotoxicity in Chinese early‑stage breast cancer patients: a candidate gene study.

    Future oncology (London, England)·2026

    TroFuse-011 study design: sacituzumab tirumotecan with or without pembrolizumab for advanced triple-negative breast cancer with PD-L1 CPS <10.

    Future oncology (London, England)·2026

    Treatment patterns in relapsed/refractory marginal zone lymphoma: real-world evidence from seven countries.

    Future oncology (London, England)·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us